Cargando…
Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection
Whether the associations between serum vitamin D (VitD) and metabolic-associated fatty liver disease (MAFLD) vary with chronic hepatitis B (CHB) infection has not been well established. This study aims to investigate the relationships between serum VitD and metabolism, liver fat content (LFC) and fi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147199/ https://www.ncbi.nlm.nih.gov/pubmed/35631255 http://dx.doi.org/10.3390/nu14102114 |
_version_ | 1784716749430587392 |
---|---|
author | Luo, Ling Ye, Junzhao Shao, Congxiang Lin, Yansong Sun, Yanhong Feng, Shiting Wang, Wei Zhong, Bihui |
author_facet | Luo, Ling Ye, Junzhao Shao, Congxiang Lin, Yansong Sun, Yanhong Feng, Shiting Wang, Wei Zhong, Bihui |
author_sort | Luo, Ling |
collection | PubMed |
description | Whether the associations between serum vitamin D (VitD) and metabolic-associated fatty liver disease (MAFLD) vary with chronic hepatitis B (CHB) infection has not been well established. This study aims to investigate the relationships between serum VitD and metabolism, liver fat content (LFC) and fibrosis among MAFLD patients with and without CHB. Consecutive subjects (healthy controls: 360, CHB: 684, MAFLD: 521, CHB with MAFLD: 206) were prospectively enrolled between January 2015 and December 2021. Anthropometric, laboratory, imaging, and histological evaluations were conducted, with LFC measured via magnetic resonance imaging-based proton density fat fraction (MRI-PDFF). Serum VitD levels were lower in MAFLD patients than in healthy controls and patients with CHB alone or overlapping with MAFLD (24.4 ± 8.1 vs. 29.0 ± 9.5 vs. 27.4 ± 9.6 vs. 26.8 ± 8.4 ng/mL respectively; p < 0.001 in one-way ANOVA test). After adjusting for confounding factors, including season, hypersensitive C-reactive protein, insulin resistance, liver stiffness measurements, sun exposure, exercise and dietary intake, multivariate linear regression analysis revealed that VitD remained significantly negatively correlated with LFC in MAFLD patients (β = −0.38, p < 0.001), but not in CHB with MAFLD patients. Moreover, quantile regression models also demonstrated that lower VitD tertiles were inversely associated with the risk of insulin resistance and moderate–severe steatosis in the MAFLD group (p for trend <0.05) but not in the MAFLD with CHB group. VitD deficiency was associated with the severity of metabolic abnormalities and steatosis independent of lifestyle factors in MAFLD-alone subjects but not in MAFLD with CHB subjects. |
format | Online Article Text |
id | pubmed-9147199 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91471992022-05-29 Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection Luo, Ling Ye, Junzhao Shao, Congxiang Lin, Yansong Sun, Yanhong Feng, Shiting Wang, Wei Zhong, Bihui Nutrients Article Whether the associations between serum vitamin D (VitD) and metabolic-associated fatty liver disease (MAFLD) vary with chronic hepatitis B (CHB) infection has not been well established. This study aims to investigate the relationships between serum VitD and metabolism, liver fat content (LFC) and fibrosis among MAFLD patients with and without CHB. Consecutive subjects (healthy controls: 360, CHB: 684, MAFLD: 521, CHB with MAFLD: 206) were prospectively enrolled between January 2015 and December 2021. Anthropometric, laboratory, imaging, and histological evaluations were conducted, with LFC measured via magnetic resonance imaging-based proton density fat fraction (MRI-PDFF). Serum VitD levels were lower in MAFLD patients than in healthy controls and patients with CHB alone or overlapping with MAFLD (24.4 ± 8.1 vs. 29.0 ± 9.5 vs. 27.4 ± 9.6 vs. 26.8 ± 8.4 ng/mL respectively; p < 0.001 in one-way ANOVA test). After adjusting for confounding factors, including season, hypersensitive C-reactive protein, insulin resistance, liver stiffness measurements, sun exposure, exercise and dietary intake, multivariate linear regression analysis revealed that VitD remained significantly negatively correlated with LFC in MAFLD patients (β = −0.38, p < 0.001), but not in CHB with MAFLD patients. Moreover, quantile regression models also demonstrated that lower VitD tertiles were inversely associated with the risk of insulin resistance and moderate–severe steatosis in the MAFLD group (p for trend <0.05) but not in the MAFLD with CHB group. VitD deficiency was associated with the severity of metabolic abnormalities and steatosis independent of lifestyle factors in MAFLD-alone subjects but not in MAFLD with CHB subjects. MDPI 2022-05-18 /pmc/articles/PMC9147199/ /pubmed/35631255 http://dx.doi.org/10.3390/nu14102114 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Luo, Ling Ye, Junzhao Shao, Congxiang Lin, Yansong Sun, Yanhong Feng, Shiting Wang, Wei Zhong, Bihui Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection |
title | Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection |
title_full | Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection |
title_fullStr | Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection |
title_full_unstemmed | Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection |
title_short | Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection |
title_sort | vitamin d status presents different relationships with severity in metabolic-associated fatty liver disease patients with or without hepatitis b infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147199/ https://www.ncbi.nlm.nih.gov/pubmed/35631255 http://dx.doi.org/10.3390/nu14102114 |
work_keys_str_mv | AT luoling vitamindstatuspresentsdifferentrelationshipswithseverityinmetabolicassociatedfattyliverdiseasepatientswithorwithouthepatitisbinfection AT yejunzhao vitamindstatuspresentsdifferentrelationshipswithseverityinmetabolicassociatedfattyliverdiseasepatientswithorwithouthepatitisbinfection AT shaocongxiang vitamindstatuspresentsdifferentrelationshipswithseverityinmetabolicassociatedfattyliverdiseasepatientswithorwithouthepatitisbinfection AT linyansong vitamindstatuspresentsdifferentrelationshipswithseverityinmetabolicassociatedfattyliverdiseasepatientswithorwithouthepatitisbinfection AT sunyanhong vitamindstatuspresentsdifferentrelationshipswithseverityinmetabolicassociatedfattyliverdiseasepatientswithorwithouthepatitisbinfection AT fengshiting vitamindstatuspresentsdifferentrelationshipswithseverityinmetabolicassociatedfattyliverdiseasepatientswithorwithouthepatitisbinfection AT wangwei vitamindstatuspresentsdifferentrelationshipswithseverityinmetabolicassociatedfattyliverdiseasepatientswithorwithouthepatitisbinfection AT zhongbihui vitamindstatuspresentsdifferentrelationshipswithseverityinmetabolicassociatedfattyliverdiseasepatientswithorwithouthepatitisbinfection |